mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-05 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.43 |
4e-05 |